Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Shattuck Labs, Inc. (STTK)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 41,740,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Shattuck Labs is a clinical-stage biopharmaceutical company engaged in developing dual-sided fusion proteins, including its Agonist Redirected Checkpoint and GADLEN™ platforms, as classes of biologic medicines capable of multifunctional activity with applications in oncology and inflammatory diseases. Co.'s product candidate SL-172154, which is in Phase 1 clinical trial for the treatment of patients with ovarian cancer. Co.'s second product candidate, SL-279252, which is developed to inhibit the PD-1/PD-L1 interaction and activate the OX40 costimulatory receptor and is in Phase 1 clinical trial in patients with solid tumors and lymphoma. Co. has several compounds in preclinical development.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 16,004 41,004 41,004 41,004
Total Sell Value $168,522 $418,522 $418,522 $418,522
Total People Sold 1 2 2 2
Total Sell Transactions 1 2 2 2
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 133
  Page 2 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Golumbeski George Director   –       •      –    2022-04-26 4 B $3.63 $102,838 D/D 28,330 54,613 2.39     -
   Golumbeski George Director   –       •      –    2022-04-22 4 B $3.67 $859 D/D 234 26,283 2.31     -
   Golumbeski George Director   –       •      –    2022-04-21 4 B $3.69 $96,121 D/D 26,049 26,049 2.39     -
   Shukla Abhinav A. Chief Technical OfficerOfficer   •       –      –    2022-04-07 3 IO $0.00 $0 D/D 0 22,325     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2022-01-28 4 OE $4.67 $18,334 D/D 3,926 17,052     -
   Brous Tyler Director   –       •      –    2022-01-19 4 B $6.87 $20,610 D/D 3,000 229,672 2.39     -
   Brous Tyler Director   –       •      –    2022-01-18 4 B $7.01 $17,525 D/D 2,500 226,672 2.39     -
   Brous Tyler Director   –       •      –    2022-01-14 4 B $7.16 $17,900 D/D 2,500 224,172 2.39     -
   Thomson Erin Ator General Counsel   •       –      –    2022-01-12 4 OE $2.95 $29,500 D/D 10,000 79,084     -
   Thomson Erin Ator General Counsel   •       –      –    2022-01-10 4 A $0.00 $0 D/D 22,825 69,084     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2022-01-10 4 A $0.00 $0 D/D 34,738 140,904     -
   Neill Andrew R Chief Financial Officer   •       –      –    2022-01-10 4 A $0.00 $0 D/D 33,325 109,491     -
   Deyoung Casi Chief Business Officer   •       –      –    2022-01-10 4 A $0.00 $0 D/D 21,363 21,363     -
   Neill Andrew R Chief Financial Officer   •       –      –    2021-11-11 4 OE $2.95 $59,000 D/D 20,000 76,166     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2021-11-10 4 OE $4.67 $18,334 D/D 3,926 13,126     -
   Thomson Erin Ator General Counsel   •       –      –    2021-10-19 4 AS $19.50 $643,500 D/D (33,000) 46,259     -
   Neill Andrew R Chief Financial Officer   •       –      –    2021-08-10 4 OE $0.01 $22 D/D 2,203 56,166     -
   Schreiber Taylor Chief Executive Officer   •       •      –    2021-08-10 4 OE $4.67 $18,334 D/D 3,926 9,200     -
   Pandite Arundathy N. Chief Medical Officer   •       –      –    2021-08-10 4 OE $0.01 $43 D/D 4,259 106,166     -
   Neill Andrew R Chief Financial Officer   •       –      –    2021-07-15 4 AS $22.13 $44,263 D/D (2,000) 53,963     -
   Thomson Erin Ator General Counsel   •       –      –    2021-07-15 4 AS $22.18 $44,367 D/D (2,000) 79,259     -
   Hornblower Josiah Director   –       •      –    2021-07-15 4 AS $22.74 $773 I/I (34) 2,966,709     -
   Hornblower Josiah Director   –       •      –    2021-07-14 4 AS $23.14 $278,784 I/I (12,049) 2,966,743     -
   Hornblower Josiah Director   –       •      –    2021-07-13 4 AS $25.12 $109,426 I/I (4,356) 2,978,792     -
   Hornblower Josiah Director   –       •      –    2021-07-12 4 AS $26.15 $73,983 I/I (2,829) 2,983,148     -
  133 Records found
  1  2  3  4  5  6   
  Page 2 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us